[go: up one dir, main page]

AR062167A1 - Sistema de administracion gastrorretentivo - Google Patents

Sistema de administracion gastrorretentivo

Info

Publication number
AR062167A1
AR062167A1 ARP070103384A ARP070103384A AR062167A1 AR 062167 A1 AR062167 A1 AR 062167A1 AR P070103384 A ARP070103384 A AR P070103384A AR P070103384 A ARP070103384 A AR P070103384A AR 062167 A1 AR062167 A1 AR 062167A1
Authority
AR
Argentina
Prior art keywords
tablet
administration system
gastrorretentive
patient
length
Prior art date
Application number
ARP070103384A
Other languages
English (en)
Inventor
Wolfram Eisenreich
Thomas Friedl
Sebastian Haertter
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of AR062167A1 publication Critical patent/AR062167A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composicion farmacéutica para la fabricacion de un sistema de administracion de fármacos gastrorretentivo que comprende una formulacion farmacéutica y una condicion de aplicacion de ésta. Reivindicacion 1: Un comprimido que comprende al menos un ingrediente activo, que se caracteriza porque el menos la longitud del comprimido en el estado anterior a la aplicacion es al menos 7/12, más preferiblemente al menos 8/12, más preferiblemente al menos 9/12, más preferiblemente al menos 10/12, más preferiblemente al menos 11/12, más preferiblemente al menos 12/12, más preferiblemente al menos 13/12, más preferiblemente al menos 14/12, más preferiblemente al menos 15/12, más preferiblemente 15/12, más preferiblemente al menos 16/12, más preferiblemente al menos 17/12, más preferiblemente al menos 18/12, más preferiblemente al menos 19/12, y más preferiblemente al menos 20/12 del diámetro pilorico del paciente, y después de ingerirlo en estado alimentado, la longitud del comprimido crece en el estomago hasta al menos 11/12, más preferiblemente al menos 12/12, más preferiblemente al menos 13/12, más preferiblemente al menos 14/12, y más preferiblemente al menos 15/12 del diámetro pilorico del paciente.
ARP070103384A 2006-08-01 2007-08-01 Sistema de administracion gastrorretentivo AR062167A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06118268A EP1886665A1 (en) 2006-08-01 2006-08-01 Gastro retentive delivery system

Publications (1)

Publication Number Publication Date
AR062167A1 true AR062167A1 (es) 2008-10-22

Family

ID=37772838

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070103384A AR062167A1 (es) 2006-08-01 2007-08-01 Sistema de administracion gastrorretentivo

Country Status (7)

Country Link
US (1) US20080031945A1 (es)
EP (2) EP1886665A1 (es)
JP (1) JP2009545557A (es)
AR (1) AR062167A1 (es)
CA (1) CA2657392A1 (es)
TW (1) TW200817050A (es)
WO (1) WO2008015162A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20040134A1 (es) * 2002-07-25 2004-03-06 Pharmacia Corp Forma de dosificacion de una vez al dia de pramipexol
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
PT1789021E (pt) * 2004-08-13 2011-12-22 Boehringer Ingelheim Int Formulação de comprimidos de libertação prolongada contendo pramipexole ou um seu sal farmaceuticamente aceitável
UA97084C2 (ru) 2004-08-13 2011-12-26 Бьорингер Ингельхайм Интернациональ Гмбх Пеллета пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, ее применение и капсула, которая содержит такие пеллеты
EP1988875A2 (en) * 2006-02-10 2008-11-12 Boehringer Ingelheim International GmbH Modified release formulation
WO2007090883A1 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Extended release formulation
IL219169A0 (en) * 2012-04-15 2012-07-31 Yehuda Darshan Apparatus for cleaning tissues from root canal by spinning liquid jet
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
BR112016028957B1 (pt) 2014-06-11 2021-12-14 The Brigham And Women's Hospital, Inc. Estrutura de residência gástrica
WO2016057517A1 (en) * 2014-10-07 2016-04-14 Therakine Micronized delivery material, method for manufacturing thereof and methods for application
MA40990A (fr) * 2014-11-19 2017-09-26 Biogen Ma Inc Formulations de matrice pharmaceutique comprenant du fumarate de diméthyle
AU2016342374B2 (en) 2015-10-23 2022-08-04 Nortiva Bio, Inc. Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
SG11201804384UA (en) 2015-12-08 2018-06-28 Lyndra Inc Geometric configurations for gastric residence systems
US12109305B2 (en) 2016-05-27 2024-10-08 Lyndra Therapeutics, Inc. Materials architecture for gastric residence systems
EP3518902A4 (en) 2016-09-30 2020-07-08 Lyndra, Inc. GASTRIC RESIDENCE SYSTEMS FOR LONG-TERM ADMINISTRATION OF ADAMANTANE CLASS MEDICINES
WO2018227147A1 (en) 2017-06-09 2018-12-13 Lyndra, Inc. Gastric residence systems with release rate-modulating films
WO2022194198A1 (zh) * 2021-03-17 2022-09-22 上海博志研新药物技术有限公司 一种拉考沙胺药物组合物、其制备方法及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations
CH649215A5 (de) * 1981-04-29 1985-05-15 Hoffmann La Roche Pharmazeutische praeparate.
US4424235A (en) * 1981-09-14 1984-01-03 Hoffmann-La Roche Inc. Hydrodynamically balanced controlled release compositions containing L-dopa and a decarboxylase inhibitor
GB9812426D0 (en) * 1998-06-10 1998-08-05 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
WO2001010405A1 (en) * 1999-08-04 2001-02-15 Ranbaxy Laboratories Limited Hydrodynamically balanced oral drug delivery system

Also Published As

Publication number Publication date
US20080031945A1 (en) 2008-02-07
WO2008015162A1 (en) 2008-02-07
EP2049078A1 (en) 2009-04-22
JP2009545557A (ja) 2009-12-24
CA2657392A1 (en) 2008-02-07
TW200817050A (en) 2008-04-16
EP1886665A1 (en) 2008-02-13

Similar Documents

Publication Publication Date Title
AR062167A1 (es) Sistema de administracion gastrorretentivo
AR039744A1 (es) Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
GT200600445A (es) Formas de presentación farmaceuticas solidas de administración oral con liberacion rapida del principio activo.
EP2248519A3 (en) Non-mucoadhesive film dosage forms
EP2364144A4 (en) GALENIC FORM FOR INSERTION IN THE MOUTH
WO2008027854A3 (en) Pharmaceutical compositions comprising hgh for oral delivery
BR0213175A (pt) Forma galênica oral macroparticular para a liberação retardada e controlada de princìpios ativos farmacêuticos
HRP20121072T1 (hr) Postupci za davanje tetrahidrobiopterina, povezani pripravci i postupci mjerenja
NZ603579A (en) Controlled release formulations
AR061771A1 (es) Sistema de administracion terapeutica
BR112012030641B8 (pt) Usos e composições para terapia farmacêutica oral
DE60121301D1 (de) Flibanserin zur Behandlung extrapyramidaler Bewegungsstörungen
AR062583A1 (es) Sistema de suministro de farmaco oral gastro-retentivo de liberacion extendida para valsartan
AR077284A1 (es) Composiciones de dosis fija farmaceuticas solidas que comprenden irbesartan y amlodipina, su preparacion y su aplicacion terapeutica
AR045783A1 (es) Composición farmacéutica que comprende un antagonista del receptor p2x7 y una droga anti-inflamatoria no esteroide
NZ591408A (en) Paracetamol and Calcium carbonate composition
EA201170108A1 (ru) Сосательная композиция для лечения воспалительных заболеваний полости рта и глотки
HRP20240812T1 (hr) Oblici doziranja i terapijska primjena l-4-klorokinurenina
AR048806A1 (es) Uso de cariofilenos en la elaboracion de medicamentos y tratamiento de afecciones corporales de inflamacion y dolor inflamatorio
AR066666A1 (es) Composicion farmaceutica que comprende la combinacion de un agente antiinflamatorio no esteroideo y un agente anticonvulsivante
AR048318A1 (es) Formulaciones de matriz orales que comprenden licarbazepina
BRPI0607172A2 (pt) método para a ministração de pelo menos uma substáncia farmaceuticamente ativa a um paciente, combinação de medicamentos e uso de pelo menos uma substáncia farmaceuticamente ativa para a fabricação de uma combinação de medicamentos
RU2011113733A (ru) Производные 1-амино-алкилциклогексана для лечения когнитивного нарушения при шуме в ушах
Alsaide et al. Insights into medicated films as attractive dosage forms
AR074246A1 (es) Derivados de 1-amino-alquilciclohexano para el tratamiento de trastornos del sueno

Legal Events

Date Code Title Description
FA Abandonment or withdrawal